Canakinumab Subcutaneous and Cleocin Pediatric
Determining the interaction of Canakinumab Subcutaneous and Cleocin Pediatric and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: clindamycin
Brand name: Cleocin Pediatric, Cleocin, Cleocin HCl, Cleocin Phosphate, Cleocin Phosphate ADD-Vantage, Clindesse, ClindaMax Vaginal
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Cleocin Pediatric Oral
- Canakinumab Subcutaneous-Cleocin Phosphate
- Canakinumab Subcutaneous-Cleocin Phosphate IV
- Canakinumab Subcutaneous-Cleocin T
- Canakinumab Subcutaneous-Cleocin T (Clindamycin Gel and Lotion)
- Canakinumab Subcutaneous-Cleocin T (Clindamycin Solution and Swab)
- Cleocin Pediatric-Canasa
- Cleocin Pediatric-Canasa Pac rectal
- Cleocin Pediatric-Canasa rectal
- Cleocin Pediatric-Cancidas
- Cleocin Pediatric-Candesartan
- Cleocin Pediatric-Candesartan and Hydrochlorothiazide